Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 286A is part of the large C2H2-type zinc finger transcription factor family, which are characterized by repeating zinc finger domains that bind DNA in sequence-specific manners and regulate transcription of target genes[1][2][3]. These proteins play major roles in various cellular processes, such as gene expression, cell differentiation, proliferation, and apoptosis[1][2]. ZNF286A contains multiple C2H2-type zinc finger motifs, which enable its function in DNA binding and interaction with other transcriptional regulators[3]. Members of the zinc finger protein family, including ZNF286A, are broadly involved in normal development and disease (especially cancer), but ZNF286A itself does not have specific, well-characterized links to therapeutic intervention or drug action at this time[1][2][3].
Mechanism is via DNA binding and regulation of transcription
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 286A (ZNF286A).